DVT & Pulmonary Embolism
Conference Coverage
Pulmonary embolism common in patients hospitalized for syncope
Pulmonary embolism was identified in approximately 17% of adults hospitalized for a first episode of syncope, according to a recent study.
Conference Coverage
Algorithm for suspected pulmonary embolism safely cut CT rate
ROME – A simplified algorithm for management of patients with suspected pulmonary embolism safely excluded the disorder with less need for CT...
Expert Commentary
Compelling case for NOACs in VTE
“This is a big-ticket winner,” expert says.
News
New guidelines update VTE treatment recommendations
Compression stockings are out for preventing postthrombotic syndrome
Conference Coverage
Andexanet reverses anticoagulant effects of factor Xa inhibitors
Key clinical point:Andexanet reverses the anticoagulant effects of factor Xa inhibitors rivaroxaban and apixaban in healthy older adults.
Conference Coverage
CHEST: Catheter-directed thrombolysis shows pulmonary embolism efficacy
Key clinical point: Catheter-directed thrombolysis was linked to reduced mortality, compared with systemic thrombolysis in patients with an acute...
News
Idarucizumab approved as first agent to reverse a novel oral anticoagulant
Conference Coverage
HIT risk rises with obesity
Higher body mass index is strongly associated with increased rates of heparin-induced thrombocytopenia
News
Home VTE treatment with rivaroxaban safe and effective
Key clinical point: Home treatment with rivaroxaban for patients with a low-risk first deep vein thrombosis or pulmonary embolism is safe and...
Conference Coverage
High VTE recurrence risk persists for at least 3 years
The risk of recurrence following an initial episode of venous thromboembolism is highest in the first 3 months, but remains high for up to 3 years...
News
Extended warfarin delays return of unprovoked pulmonary embolism
Key clinical point: Eighteen additional months of warfarin therapy delays the recurrence of unprovoked pulmonary embolism. Major finding: During...